Phys Clinical Cases · rheumatological
Immunological Investigation Immunoglobulins Complement Flow Cytometry — DCE Clinical Case
DCE long-case and short-case station for Immunological Investigation Immunoglobulins Complement Flow Cytometry.
On this page & tools
Target exams
Immunological Investigation Immunoglobulins Complement Flow Cytometry — Clinical Case
DCE Long Case
Patient brief
Patient: A middle-aged or older adult with multimorbidity and a presentation centred on Immunological Investigation Immunoglobulins Complement Flow Cytometry. [1]
Presenting complaint: Subacute or acute symptoms referable to Immunological Investigation Immunoglobulins Complement Flow Cytometry, with enough detail to force prioritisation. [1] [2]
Past history: Common cardiometabolic and organ comorbidities that interact with the plan. [2]
Medications: A polypharmacy list that includes at least one interaction or dosing issue. [2]
Examination: Key positives and critical negatives for dangerous differentials. [1]
Investigations: A small set of results that change management. [1] [2]
Tasks
- Present a prioritised problem list. [1]
- Defend investigations and immediate therapy. [1] [2]
- Provide safety-net and follow-up advice. [2]
Model discussion points
- Working diagnosis and acuity. [1]
- Differentials and discriminators. [2]
- Treatment sequence and monitoring. [1] [2] [3]
- Multimorbidity and communication. [2]
Short case
Focused examination or counselling station linked to Immunological Investigation Immunoglobulins Complement Flow Cytometry, with one interpretation task and one shared-decision point. [1] [2]
References
- [1]Dialynas DP, Wilde DB, Marrack P, Pierres A, et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity Immunol Rev, 1983.PMID 6195085
- [2]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [3]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
- [4]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
- [5]Ye S, Li D, Liu F, Lei M, et al. In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations J Pharm Biomed Anal, 2018.PMID 29413980
- [6]Barth MJ, Mavis C, Czuczman MS, Hernandez-Ilizaliturri FJ Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma Clin Cancer Res, 2015.PMID 25964296
- [7]Guardiola FA, Gónzalez-Párraga MP, Cuesta A, Meseguer J, et al. Immunotoxicological effects of inorganic arsenic on gilthead seabream (Sparus aurata L.) Aquat Toxicol, 2013.PMID 23603147
- [8]Endres D, von Zedtwitz K, Nickel K, Runge K, et al. Association of rheumatological markers with neuronal antibodies, cerebrospinal fluid, electroencephalography, and magnetic resonance imaging findings in 224 patients with psychotic syndromes Brain Behav Immun, 2024.PMID 38599500